KaloBios Pharmaceuticals Garners $17,000,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bdbe52f0-9ccc-4079-96df-dc98e7992107&Preview=1 -
Date
5/22/2012 -
Company Name
KaloBios Pharmaceuticals -
Mailing Address
260 East Grand Avenue South San Francisco, CA 94080 -
Company Description
KaloBios is a vertically integrated therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics. -
Website
http://www.kalobios.com -
Transaction Type
Venture Equity -
Transaction Amount
$17,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
